上海交通大学学报(医学版) ›› 2024, Vol. 44 ›› Issue (2): 250-257.doi: 10.3969/j.issn.1674-8115.2024.02.011
• 论著 · 公共卫生 • 上一篇
蒋莹1(), 李清瑶1,2(
), 陈之琦1, 汪佳璐1, 李云2, 徐仁应1(
)
收稿日期:
2023-08-10
接受日期:
2023-12-06
出版日期:
2024-02-28
发布日期:
2024-03-25
通讯作者:
徐仁应
E-mail:pinksalad@126.com;gyon071@126.com;721001735@shsmu.edu.cn
作者简介:
蒋 莹(1988—),女,主管营养师,学士;电子信箱:pinksalad@126.com
JIANG Ying1(), LI Qingyao1,2(
), CHEN Zhiqi1, WANG Jialu1, LI Yun2, XU Renying1(
)
Received:
2023-08-10
Accepted:
2023-12-06
Online:
2024-02-28
Published:
2024-03-25
Contact:
XU Renying
E-mail:pinksalad@126.com;gyon071@126.com;721001735@shsmu.edu.cn
摘要:
目的·评估老年人群体质量指数(body mass index,BMI)与慢性代谢性疾病发生风险的关系。方法·以2014—2021年在上海交通大学医学院附属仁济医院体检中心进行体检的老年人(≥60岁)为研究对象。收集其各项生化指标。由经过培训的护士测量其身高、体质量和血压。采用问卷法收集研究对象既往慢性代谢性疾病史。收缩压≥140 mmHg(1 mmHg=0.133 kPa)、舒张压≥90 mmHg或既往有高血压病史,定义为高血压。空腹血糖≥7.0 mmol/L或既往有糖尿病病史,定义为糖尿病。总胆固醇≥6.2 mmol/L、三酰甘油≥2.3 mmol/L或既往有脂代谢异常病史,定义为脂质代谢紊乱。BMI与高血压、糖尿病和脂质代谢紊乱之间的关系采用受试者操作特征(receiver operator characteristic,ROC)曲线和二元Logistic回归进行分析评估。结果·共收集59 083例研究对象的资料,其中男性30 807例,女性28 276例,平均年龄(67.9±6.3)岁。高血压、糖尿病和脂质代谢紊乱的发生率分别为76.5%(45 219/59 083)、24.1%(14 225/59 083)和50.0%(29 544/59 083)。与60~74岁的老年人群相比,75岁及以上的老年人患高血压和糖尿病的比例更高,患脂质代谢紊乱和无代谢异常的比例更低。通过ROC曲线分析,BMI对于高血压、糖尿病和脂质代谢紊乱的切点值分别为24.3、23.9和23.9 kg/m2。老年男性高血压和糖尿病的BMI切点值和老年女性十分接近(高血压BMI切点值:老年男性24.3 kg/m2vs 老年女性24.2 kg/m2;糖尿病BMI切点值:老年男性24.0 kg/m2vs 老年女性23.7 kg/m2),但老年男性脂质代谢紊乱的BMI切点值明显高于老年女性(老年男性24.0 kg/m2vs 老年女性22.5 kg/m2)。60~74岁老年人的BMI对慢性代谢性疾病的切点值(24.2~24.7 kg/m2)高于75岁及以上的老年人(22.9~23.8 kg/m2)。结论·60~74岁老年人群应将BMI控制在24.0 kg/m2以下,而75岁及以上老年人群应将BMI控制在23.0 kg/m2以下,则有利于降低其慢性代谢性疾病的风险。
中图分类号:
蒋莹, 李清瑶, 陈之琦, 汪佳璐, 李云, 徐仁应. 老年人群体质量指数与慢性代谢性疾病的关系[J]. 上海交通大学学报(医学版), 2024, 44(2): 250-257.
JIANG Ying, LI Qingyao, CHEN Zhiqi, WANG Jialu, LI Yun, XU Renying. Association between body mass index and chronic metabolic diseases in Chinese aged population[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(2): 250-257.
Clinical index | Total (n=59 083) | Male (n=30 807) | Female (n=28 276) | P value |
---|---|---|---|---|
Age/year | 67.9±6.3 | 67.9±6.4 | 67.8±6.2 | 0.030 |
Height/cm | 161.7±8.4 | 167.5±6.0 | 155.4±5.7 | 0.000 |
Body mass/kg | 64.7±10.7 | 69.6±9.9 | 59.4±9.0 | 0.000 |
BMI/(kg·m-2) | 24.7±3.2 | 24.8±3.1 | 24.6±3.4 | 0.000 |
FBG/(mmol·L-1) | 5.8±1.6 | 5.8±1.6 | 5.7±1.5 | 0.000 |
SBP/mmHg | 139.5±18.4 | 138.8±18.4 | 140.2±18.5 | 0.000 |
DBP/mmHg | 79.3±10.4 | 79.9±10.4 | 78.7±10.3 | 0.000 |
TC/(mmol·L-1) | 5.1±1.0 | 4.9±1.0 | 5.4±1.0 | 0.000 |
TAG/(mmol·L-1) | 1.40 (1.01, 1.99) | 1.36 (0.97, 1.95) | 1.46 (1.07, 2.04) | 0.000 |
ALT/(IU·L-1) | 22.0±18.5 | 22.3±17.1 | 21.6±20.0 | 0.000 |
AST/(IU·L-1) | 23.5±12.4 | 23.0±11.4 | 24.1±13.3 | 0.000 |
eGFR/[mL·(min·1.73 m2)-1] | 85.8±11.1 | 85.3±11.4 | 86.3±10.8 | 0.000 |
Hypertension/n(%) | 45 219 (76.5) | 23 137 (75.1) | 22 082 (78.1) | 0.000 |
Diabetes/n(%) | 14 225 (24.1) | 7 960 (25.8) | 6 265 (22.2) | 0.000 |
Hyperlipoidemia/n(%) | 29 544 (50.0) | 13 266 (43.1) | 16 278 (57.6) | 0.000 |
表1 59 083名老年人的一般情况
Tab 1 General information of 59 083 elderly people
Clinical index | Total (n=59 083) | Male (n=30 807) | Female (n=28 276) | P value |
---|---|---|---|---|
Age/year | 67.9±6.3 | 67.9±6.4 | 67.8±6.2 | 0.030 |
Height/cm | 161.7±8.4 | 167.5±6.0 | 155.4±5.7 | 0.000 |
Body mass/kg | 64.7±10.7 | 69.6±9.9 | 59.4±9.0 | 0.000 |
BMI/(kg·m-2) | 24.7±3.2 | 24.8±3.1 | 24.6±3.4 | 0.000 |
FBG/(mmol·L-1) | 5.8±1.6 | 5.8±1.6 | 5.7±1.5 | 0.000 |
SBP/mmHg | 139.5±18.4 | 138.8±18.4 | 140.2±18.5 | 0.000 |
DBP/mmHg | 79.3±10.4 | 79.9±10.4 | 78.7±10.3 | 0.000 |
TC/(mmol·L-1) | 5.1±1.0 | 4.9±1.0 | 5.4±1.0 | 0.000 |
TAG/(mmol·L-1) | 1.40 (1.01, 1.99) | 1.36 (0.97, 1.95) | 1.46 (1.07, 2.04) | 0.000 |
ALT/(IU·L-1) | 22.0±18.5 | 22.3±17.1 | 21.6±20.0 | 0.000 |
AST/(IU·L-1) | 23.5±12.4 | 23.0±11.4 | 24.1±13.3 | 0.000 |
eGFR/[mL·(min·1.73 m2)-1] | 85.8±11.1 | 85.3±11.4 | 86.3±10.8 | 0.000 |
Hypertension/n(%) | 45 219 (76.5) | 23 137 (75.1) | 22 082 (78.1) | 0.000 |
Diabetes/n(%) | 14 225 (24.1) | 7 960 (25.8) | 6 265 (22.2) | 0.000 |
Hyperlipoidemia/n(%) | 29 544 (50.0) | 13 266 (43.1) | 16 278 (57.6) | 0.000 |
Clinical index | 60‒74 years old (n=50 185) | ≥75 years old (n=8 898) | P value |
---|---|---|---|
Hypertension/n(%) | 37 603 (74.9) | 7 616 (85.6) | 0.000 |
Diabetes/n(%) | 11 811 (23.5) | 2 414 (27.1) | 0.000 |
Hyperlipoidemia/n(%) | 25 661 (51.1) | 3 883 (43.6) | 0.000 |
No chronic metabolic diseases/n(%) | 6 195 (12.3) | 717 (8.1) | 0.000 |
表2 各年龄组慢性代谢性疾病的发生率
Tab 2 Incidence of chronic metabolic diseases in different age groups
Clinical index | 60‒74 years old (n=50 185) | ≥75 years old (n=8 898) | P value |
---|---|---|---|
Hypertension/n(%) | 37 603 (74.9) | 7 616 (85.6) | 0.000 |
Diabetes/n(%) | 11 811 (23.5) | 2 414 (27.1) | 0.000 |
Hyperlipoidemia/n(%) | 25 661 (51.1) | 3 883 (43.6) | 0.000 |
No chronic metabolic diseases/n(%) | 6 195 (12.3) | 717 (8.1) | 0.000 |
Classification | BMI cut-off point/(kg·m-2) | Sensitivity | 1-specificity | AUC | P value |
---|---|---|---|---|---|
Total (n=59 083) | |||||
Hypertension | 24.3 | 0.57 | 0.39 | 0.62 | 0.000 |
Diabetes | 23.9 | 0.69 | 0.55 | 0.60 | 0.000 |
Hyperlipoidemia | 23.9 | 0.68 | 0.55 | 0.58 | 0.000 |
Male (n=30 807) | |||||
Hypertension | 24.3 | 0.61 | 0.44 | 0.61 | 0.000 |
Diabetes | 24.0 | 0.70 | 0.57 | 0.59 | 0.000 |
Hyperlipoidemia | 24.0 | 0.70 | 0.54 | 0.61 | 0.000 |
Female (n=28 276) | |||||
Hypertension | 24.2 | 0.56 | 0.36 | 0.63 | 0.000 |
Diabetes | 23.7 | 0.69 | 0.55 | 0.60 | 0.000 |
Hyperlipoidemia | 22.5 | 0.76 | 0.67 | 0.56 | 0.000 |
60‒74 years old (n=50 185) | |||||
Hypertension | 24.5 | 0.76 | 0.67 | 0.63 | 0.000 |
Diabetes | 24.7 | 0.59 | 0.45 | 0.60 | 0.000 |
Hyperlipoidemia | 24.2 | 0.61 | 0.51 | 0.57 | 0.000 |
≥75 years old (n=8 898) | |||||
Hypertension | 23.2 | 0.66 | 0.49 | 0.61 | 0.000 |
Diabetes | 22.9 | 0.77 | 0.63 | 0.60 | 0.000 |
Hyperlipoidemia | 23.8 | 0.65 | 0.49 | 0.60 | 0.000 |
表3 老年人群BMI切点值与慢性代谢性疾病的ROC曲线分析
Tab 3 ROC curve analysis of the relationship between BMI cut-off point and chronic metabolic diseases in the elderly
Classification | BMI cut-off point/(kg·m-2) | Sensitivity | 1-specificity | AUC | P value |
---|---|---|---|---|---|
Total (n=59 083) | |||||
Hypertension | 24.3 | 0.57 | 0.39 | 0.62 | 0.000 |
Diabetes | 23.9 | 0.69 | 0.55 | 0.60 | 0.000 |
Hyperlipoidemia | 23.9 | 0.68 | 0.55 | 0.58 | 0.000 |
Male (n=30 807) | |||||
Hypertension | 24.3 | 0.61 | 0.44 | 0.61 | 0.000 |
Diabetes | 24.0 | 0.70 | 0.57 | 0.59 | 0.000 |
Hyperlipoidemia | 24.0 | 0.70 | 0.54 | 0.61 | 0.000 |
Female (n=28 276) | |||||
Hypertension | 24.2 | 0.56 | 0.36 | 0.63 | 0.000 |
Diabetes | 23.7 | 0.69 | 0.55 | 0.60 | 0.000 |
Hyperlipoidemia | 22.5 | 0.76 | 0.67 | 0.56 | 0.000 |
60‒74 years old (n=50 185) | |||||
Hypertension | 24.5 | 0.76 | 0.67 | 0.63 | 0.000 |
Diabetes | 24.7 | 0.59 | 0.45 | 0.60 | 0.000 |
Hyperlipoidemia | 24.2 | 0.61 | 0.51 | 0.57 | 0.000 |
≥75 years old (n=8 898) | |||||
Hypertension | 23.2 | 0.66 | 0.49 | 0.61 | 0.000 |
Diabetes | 22.9 | 0.77 | 0.63 | 0.60 | 0.000 |
Hyperlipoidemia | 23.8 | 0.65 | 0.49 | 0.60 | 0.000 |
图1 BMI与慢性代谢性疾病之间的关系Note:A?C. Binary Logistic regression results of BMI with hypertension (A), diabetes (B), and hyperlipoidemia (C). The controlled variables included age, gender, ALT, AST, and eGFR. When analyzing the relationship between BMI and hypertension, further control was applied for FBG, TC, and TAG. When analyzing the relationship between BMI and diabetes, further control was applied for SBP, DBP, TC, and TAG. When analyzing the relationship between BMI and hyperlipoidemia, further control was applied for SBP, DBP, and FBG. D?F. Restricted cubic spline results of BMI with hypertension (D), diabetes (E), and hyperlipoidemia (F). The controlled variables included age and gender, and the reference value for BMI was 24.56 kg/m2.
Fig 1 Relationship between BMI and chronic metabolic diseases
1 | XIONG Y, ZHANG Y C, ZHANG F X, et al. Prevalence and associated factors of metabolic syndrome in Chinese middle-aged and elderly population: a national cross-sectional study[J]. Aging Male, 2021, 24(1): 148-159. |
2 | GE H S, YANG Z H, LI X Y, et al. The prevalence and associated factors of metabolic syndrome in Chinese aging population[J]. Sci Rep, 2020, 10(1): 20034. |
3 | ZHOU B F, Cooperative Meta-analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults[J]. Biomed Environ Sci, 2002, 15(1): 83-96. |
4 | YORKE E, TETTEH J, BOIMA V, et al. High BMI: an important health risk factor among older adults in Ghana[J]. Public Health Nutr, 2021, 24(14): 4522-4529. |
5 | ZHANG W L, HE K, ZHAO H, et al. Association of body mass index and waist circumference with high blood pressure in older adults[J]. BMC Geriatr, 2021, 21(1): 260. |
6 | WANG S K, MA W, WANG S M, et al. Obesity and its relationship with hypertension among adults 50 years and older in Jinan, China[J]. PLoS One, 2014, 9(12): e114424. |
7 | 中国营养学会. 中国居民膳食指南(2022)[M]. 北京: 人民卫生出版社, 2022. |
Chinese Nutrition Society. Dietary guidelines for Chinese residents (2022)[M]. Beijing: People's Medical Publishing House, 2022. | |
8 | BOSELLO O, VANZO A. Obesity paradox and aging[J]. Eat Weight Disord, 2021, 26(1): 27-35. |
9 | WANG J, TAYLOR A W, ZHANG T, et al. Association between body mass index and all-cause mortality among oldest old Chinese[J]. J Nutr Health Aging, 2018, 22(2): 262-268. |
10 | BHASKARAN K, DOS-SANTOS-SILVA I, LEON D A, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK[J]. Lancet Diabetes Endocrinol, 2018, 6(12): 944-953. |
11 | JAVED A A, MA J H, ANDERSON L N, et al. Age-appropriate BMI cut-points for cardiometabolic health risk: a cross-sectional analysis of the Canadian Longitudinal Study on Aging[J]. Int J Obes (Lond), 2022, 46(5): 1027-1035. |
12 | KUK J L, SAUNDERS T J, DAVIDSON L E, et al. Age-related changes in total and regional fat distribution[J]. Ageing Res Rev, 2009, 8(4): 339-348. |
13 | JAFARINASABIAN P, INGLIS J E, REILLY W, et al. Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake[J]. J Endocrinol, 2017, 234(1): R37-R51. |
14 | GRAF C E, KARSEGARD V L, SPOERRI A, et al. Body composition and all-cause mortality in subjects older than 65 y[J]. Am J Clin Nutr, 2015, 101(4): 760-767. |
15 | KAWADA T. Cancer, hypertension and risk for cardiovascular disease[J]. J Hypertens, 2021, 39(10): 2122. |
16 | ANDERS H J, HUBER T B, ISERMANN B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease[J]. Nat Rev Nephrol, 2018, 14(6): 361-377. |
17 | HAGER M R, NARLA A D, TANNOCK L R. Dyslipidemia in patients with chronic kidney disease[J]. Rev Endocr Metab Disord, 2017, 18(1): 29-40. |
18 | WOLLEY M J, STOWASSER M. Resistant hypertension and chronic kidney disease: a dangerous liaison[J]. Curr Hypertens Rep, 2016, 18(5): 36. |
19 | Levey A S, Stevens L A, Schmid C H, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612. |
20 | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. |
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chinese Journal of Diabetes Mellitus, 2021, 13(4): 315-409. | |
21 | 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华心血管病杂志, 2016, 44(10): 833-853. |
Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults. 2016 Chinese guideline for the management of dyslipidemia in adults[J]. Chinese Journal of Cardiology, 2016, 44(10): 833-853. | |
22 | 中国老年医学学会高血压分会, 国家老年疾病临床医学研究中心中国老年心血管病防治联盟. 中国老年高血压管理指南2019[J]. 中国心血管杂志, 2019, 24(1): 1-23 |
Hypertension Branch of Chinese Geriatrics Society, National Clinical Research Center for Geriatric Diseases-Chinese Alliance of Geriatric Cardiovascular Disease. 2019 Chinese guidelines for the management of hypertension in the elderly[J]. Chinese Journal of Cardiovascular Medicine, 2019, 24(1):1-23. | |
23 | CHEN Y J, LIANG X, ZHENG S S, et al. Association of body fat mass and fat distribution with the incidence of hypertension in a population-based Chinese cohort: a 22-year follow-up[J]. J Am Heart Assoc, 2018, 7(6): e007153. |
24 | BADR H E, SHAH N M, SHAH M A. Obesity among Kuwaitis aged 50 years or older: prevalence, correlates, and comorbidities[J]. Gerontologist, 2013, 53(4): 555-566. |
25 | RAHMAN M, ZAMAN M M, ISLAM J Y, et al. Prevalence, treatment patterns, and risk factors of hypertension and pre-hypertension among Bangladeshi adults[J]. J Hum Hypertens, 2018, 32(5): 334-348. |
26 | HSU C H, LIN J D, HSIEH C H, et al. Adiposity measurements in association with metabolic syndrome in older men have different clinical implications[J]. Nutr Res, 2014, 34(3): 219-225. |
27 | SEOK LEE H, PARK Y M, HAN K, et al. Obesity-related hypertension: findings from the Korea national health and nutrition examination survey 2008‒2010[J]. PLoS One, 2020, 15(4): e0230616. |
28 | DAS S, DEBNATH M, DAS S, et al. Association of overweight and obesity with hypertension, diabetes and comorbidity among adults in Bangladesh: evidence from nationwide Demographic and Health Survey 2017‒2018 data[J]. BMJ Open, 2022, 12(7): e052822. |
29 | SASAI H, SAIRENCHI T, ISO H, et al. Relationship between obesity and incident diabetes in middle-aged and older Japanese adults: the Ibaraki Prefectural Health Study[J]. Mayo Clin Proc, 2010, 85(1): 36-40. |
30 | EBRAHIMI H, EMAMIAN M H, HASHEMI H, et al. Dyslipidemia and its risk factors among urban middle-aged Iranians: a population-based study[J]. Diabetes Metab Syndr, 2016, 10(3): 149-156. |
31 | LIN H Q, WU J Y, CHEN M L, et al. Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study[J]. Clin Interv Aging, 2019, 14: 1119-1129. |
32 | XI Y F, NIU L W, CAO N, et al. Prevalence of dyslipidemia and associated risk factors among adults aged ≥35 years in Northern China: a cross-sectional study[J]. BMC Public Health, 2020, 20(1): 1068. |
33 | VAN HEMELRIJCK M, ULMER H, NAGEL G, et al. Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60, 000 men and women in Sweden and Austria[J]. PLoS One, 2018, 13(6): e0197830. |
34 | PIKILIDOU M I, SCUTERI A, MORRELL C, et al. The burden of obesity on blood pressure is reduced in older persons: the SardiNIA study[J]. Obesity, 2013, 21(1): E10-E13. |
35 | CANNING K L, BROWN R E, JAMNIK V K, et al. Relationship between obesity and obesity-related morbidities weakens with aging[J]. J Gerontol A Biol Sci Med Sci, 2014, 69(1): 87-92. |
36 | CHENG F W, GAO X, MITCHELL D C, et al. Metabolic health status and the obesity paradox in older adults[J]. J Nutr Gerontol Geriatr, 2016, 35(3): 161-176. |
37 | BOWMAN K, DELGADO J, HENLEY W E, et al. Obesity in older people with and without conditions associated with weight loss: follow-up of 955, 000 primary care patients[J]. J Gerontol A Biol Sci Med Sci, 2017, 72(2): 203-209. |
38 | KıSKAÇ M, SOYSAL P, SMITH L, et al. What is the optimal body mass index range for older adults?[J]. Ann Geriatr Med Res, 2022, 26(1): 49-57. |
39 | DI RENZO L, ITANI L, GUALTIERI P, et al. New BMI cut-off points for obesity in middle-aged and older adults in clinical nutrition settings in Italy: a cross-sectional study[J]. Nutrients, 2022, 14(22): 4848. |
40 | KUWABARA M, KUWABARA R, NIWA K, et al. Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects[J]. Nutrients, 2018, 10(8): 1011. |
[1] | 王俊琳, 郝明秀, 唐吟菡, 吴芸芸, 金玉华, 胡耀敏. 慢性病共病、相位角与老年人肌少症相关的肌肉质量减少的关系研究[J]. 上海交通大学学报(医学版), 2024, 44(2): 196-203. |
[2] | 王雅玉, 蒋惠如, 叶梦月, 李萍, 袁安彩, 张薇, 卜军. 上海社区老年人群脑卒中与体力活动的关联性研究[J]. 上海交通大学学报(医学版), 2023, 43(11): 1348-1358. |
[3] | 刘秋利, 江来, 翁晓建. 老年患者全身麻醉术后肌松残余的研究进展[J]. 上海交通大学学报(医学版), 2023, 43(1): 108-113. |
[4] | 赖秀秀, 朱青燕, 谈佳奇, 杨令, 朱琰, 周公民. 小剂量非布司他改善无症状高尿酸血症高龄患者肾功能的临床研究[J]. 上海交通大学学报(医学版), 2022, 42(7): 885-892. |
[5] | 崔培荣, 倪雪萍, 宗明灿, 忻笑, 江雨露, 李贤华. 老年慢性病患者健康信息寻求行为现状及影响因素路径分析[J]. 上海交通大学学报(医学版), 2022, 42(6): 805-812. |
[6] | 陆雪梅, 陈兰. 改良危重症营养风险评分在老年危重症患者中的应用[J]. 上海交通大学学报(医学版), 2022, 42(1): 16-20. |
[7] | 黄道, 韦栋, 徐志红, 胡家安. 老年呼吸道病毒感染119例临床特征分析[J]. 上海交通大学学报(医学版), 2021, 41(5): 628-631. |
[8] | 代华杰, 禤立平, 项家丽, 林泓, 赵志云, 王天歌, 李勉, 徐瑜, 陆洁莉, 王卫庆, 毕宇芳, 徐敏. 上海市社区中老年人群健康的血管衰老和心血管疾病患病风险的相关性研究[J]. 上海交通大学学报(医学版), 2021, 41(2): 223-227. |
[9] | 吕晓亚, 宋磊, 马昭, 王曙光, 马豪, 邵一鸣, 武治印. 新型冠状病毒疫苗免疫策略的强化和优化[J]. 上海交通大学学报(医学版), 2021, 41(12): 1545-1550. |
[10] | 吴志山, 黄润, 梁丽萍, 朱宇婷, 郑乔木, 姜丽萍. ICU老年患者术后谵妄发生的特征及影响因素分析[J]. 上海交通大学学报(医学版), 2021, 41(12): 1580-1586. |
[11] | 栾 伟1, 2*,朱 珠2*,朱冬平2,葛文静2,朱群妹3,蒋燕勤2,李 劲2,姜安丽1. 城乡结合社区老年人健康促进生活方式与社会支持、自我效能感相关性研究[J]. 上海交通大学学报(医学版), 2020, 40(1): 107-. |
[12] | 盛长生,黄绮芳,黄剑峰,李燕,王继光. 上海老年人四肢血压差别异常的患病情况及相关因素[J]. 上海交通大学学报(医学版), 2019, 39(3): 287-. |
[13] | 路会萍*,吴李娜*,汪海娅. 社区门诊老年高血压患者自测健康调查及其影响因素分析[J]. 上海交通大学学报(医学版), 2019, 39(10): 1194-. |
[14] | 刘霞 1, 2,丁飚 3,章雅青 1. 经皮冠状动脉介入治疗老年患者焦虑、抑郁情绪与睡眠质量及生活质量的相关性[J]. 上海交通大学学报(医学版), 2018, 38(9): 1085-. |
[15] | 董凤伟,马佳莉,张莹. 合并慢性病的老年心房颤动患者消融术后复发危险因素研究[J]. 上海交通大学学报(医学版), 2018, 38(9): 1092-. |
阅读次数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
全文 509
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
摘要 292
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||